This brand name is authorized in Austria, Finland, Netherlands, Poland, Romania, Turkey
The drug ORGAMETRIL contains one active pharmaceutical ingredient (API):
1
Lynestrenol
UNII N2Z8ALG4U5 - LYNESTRENOL
|
Lynestrenol is an oral preparation of the synthetic progestagen, which shares various activities with the natural hormone progesterone. Lynestrenol has a strong progestational influence on the endometrium. In addition it suppresses the ovulation and menstruation for as long as the preparation is taken daily without interruption. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
ORGAMETRIL Tablet | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
G03DC03 | Lynestrenol | G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03D Progestogens → G03DC Estren derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 121253 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 1996 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100049693, 100386574, 100400469, 100407112, 100419500, 100419747, 100424300, 100427907, 100437930, 100438740, 100438963, 100458609, 100466791 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W68114001 |
Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8683280337336 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.